Drug Utilization Review (DUR)
Drug Utilization Review, or DUR, remains a steadfast component of clinical
information systems and pharmacy management systems. A requirement of OBRA '90,
Drug Utilization Review enables clinicians to view and address potential conflicts
associated with a patient's drug therapy.
Medi-Span® provides the wealth of drug information necessary to ensure a patient's
medication is optimized and safe, and the clinician is supported with accurate,
up-to-date information at every decision point.
If you are looking for tools to support Drug Utilization Review, these products
will interest you:
Databases
Adverse Drug Effects Database™ Drug Dosing & Administration
Database™ Drug Indications Database™ Drug Lab Conflict Database™ Drug
Therapy Monitoring System™ (DTMS) v2.1/
DTMS Consumer Monographs Duplicate Therapy Database™ Integrated A to Z Drug Facts™
Module Master Drug Data Base v2.5 (MDDB®) Master Parameters Database™ Medi-Span Electronic Drug File™
(MED-File) Medical Conditions Master
Database™ Medication Order Management
Database™ (MOMD) Parameters to Monitor Database™
Precautions Database™ Rx Norm Cross-Reference File Standard Drug Identifiers
Database Supplemental Names File Tools
Drug Information Bridge™ v3.2 Integrated Drug Facts
and Comparisons™ API v3.1